Cost-effectiveness analysis of chemoradiotherapy compared to surgery in patients with stage I esophageal squamous cell carcinoma in Japan
Takuro Ariga, Kensuke Moriwaki, Kousuke Morimoto, Katsuyuki Sakanaka, Yoshinori Ito, Tetsuo Saito, Atsuto Katano, Satoru Matsuda, Ken Kato, Hiroya Takeuchi, Hiroshi Onishi, The Japanese Society for Radiation Oncology (JASTRO) Health Insurance Committee · 2026
Read Cost-effectiveness analysis of chemoradiotherapy compared to surgery in patients with stage I esophageal squamous cell carcinoma in Japan by Takuro Ariga, Kensuke Moriwaki, Kousuke Morimoto, Katsuyuki Sakanaka, Yoshinori Ito, Tetsuo Saito, Atsuto Katano, Satoru Matsuda, Ken Kato, Hiroya Takeuchi, Hiroshi Onishi, The Japanese Society for Radiation Oncology (JASTRO) Health Insurance Committee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13615109.txt.
Description
Takuro Ariga and colleagues compare in 2026 the cost-effectiveness of chemoradiotherapy against surgery for stage I cancer of the oesophagus in Japan, the earliest stage of the disease. Their model combined survival figures from a Japanese trial with quality-of-life scores mapped from standard cancer questionnaires, counting only direct medical costs from the public health system's view. Future costs and life years were discounted at 2 percent per year.
The drug and radiation route cost about 26,313 United States dollars more than surgery, while adding 0.630 quality-adjusted life years, giving a ratio near 41,742 dollars per such year. Checks on the model's weak points showed which inputs moved the answer most. For a health system weighing two good treatments, the study prices the gentler, organ-keeping option in terms officials can judge.
Catalog record
| CREATOR | Takuro Ariga, Kensuke Moriwaki, Kousuke Morimoto, Katsuyuki Sakanaka, Yoshinori Ito, Tetsuo Saito, Atsuto Katano, Satoru Matsuda, Ken Kato, Hiroya Takeuchi, Hiroshi Onishi, The Japanese Society for Radiation Oncology (JASTRO) Health Insurance Committee |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34691 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |